Literature DB >> 3834349

Cancer incidence in the islands of the Pacific.

B E Henderson, L N Kolonel, R Dworsky, D Kerford, E Mori, K Singh, H Thevenot.   

Abstract

The South Pacific Commission Cancer Registry has been operational since 1977, and reasonably complete cancer incidence rates are available for New Caledonia, Fiji, Micronesia, the Cook Islands, and Niue. In addition, less complete reporting is available from American Samoa, Papua New Guinea, and French Polynesia. Cancers of the lung, oral cavity, esophagus, liver, and cervix are potentially preventable but prevalent in many Pacific island countries. Unusually low rates of many cancers were observed in Fiji, the most notable being lung and colon-rectum. Thyroid cancer rates are elevated in some but not all female populations. These and other variations in cancer by site are important areas for further research.

Entities:  

Mesh:

Year:  1985        PMID: 3834349

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  17 in total

1.  An epidemiologic study of thyroid cancer in Hawaii.

Authors:  L N Kolonel; J H Hankin; L R Wilkens; F H Fukunaga; M W Hinds
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

2.  Projected lifetime cancer risks from exposure to regional radioactive fallout in the Marshall Islands.

Authors:  Charles E Land; André Bouville; Iulian Apostoaei; Steven L Simon
Journal:  Health Phys       Date:  2010-08       Impact factor: 1.316

3.  Kava blocks 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in association with reducing O6-methylguanine DNA adduct in A/J mice.

Authors:  Pablo Leitzman; Sreekanth C Narayanapillai; Silvia Balbo; Bo Zhou; Pramod Upadhyaya; Ahmad Ali Shaik; M Gerard O'Sullivan; Stephen S Hecht; Junxuan Lu; Chengguo Xing
Journal:  Cancer Prev Res (Phila)       Date:  2014-01

4.  The Impact of One-week Dietary Supplementation with Kava on Biomarkers of Tobacco Use and Nitrosamine-based Carcinogenesis Risk among Active Smokers.

Authors:  Yi Wang; Sreekanth C Narayanapillai; Katelyn M Tessier; Lori G Strayer; Pramod Upadhyaya; Qi Hu; Rick Kingston; Ramzi G Salloum; Junxuan Lu; Stephen S Hecht; Dorothy K Hatsukami; Naomi Fujioka; Chengguo Xing
Journal:  Cancer Prev Res (Phila)       Date:  2020-02-26

Review 5.  Fasting and cancer: molecular mechanisms and clinical application.

Authors:  Alessio Nencioni; Irene Caffa; Salvatore Cortellino; Valter D Longo
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

6.  A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China).

Authors:  S Preston-Martin; F Jin; M J Duda; W J Mack
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

7.  Thyroid cancer incidence in Asian migrants to the United States and their descendants.

Authors:  M A Rossing; S M Schwartz; N S Weiss
Journal:  Cancer Causes Control       Date:  1995-09       Impact factor: 2.506

8.  Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53.

Authors:  Yaxiong Tang; Anne R Simoneau; Jun Xie; Babbak Shahandeh; Xiaolin Zi
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

9.  Kava, a tonic for relieving the irrational development of natural preventive agents.

Authors:  Rajesh Agarwal; Gagan Deep
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

10.  Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol.

Authors:  R V Cooney; A A Franke; P J Harwood; V Hatch-Pigott; L J Custer; L J Mordan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.